ANDE Stock

ande.comHealthcareFounded: 2004Funding to Date: $128.92MM

ANDE is the developer of rapid DNA analysis technology designed to help reduce crime, exonerate innocent, monitor borders, and reunite families.

Register for Details

For more details on financing and valuation for ANDE, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for ANDE.

Register Today

ANDE investors also invested in these private companies

Eastward Capital Partners
MassVentures

Team

Management Team

John Rose
Chief Financial Officer
George Heinrichs
Chief Executive Officer & Board Member
Richard Selden
Founder, Chairman & Chief Scientific Officer
Mary Consalvi
General Counsel

Board Members

David Kronfeld
ANDE
Beth Kronfeld
ANDE
George Heinrichs
ANDE
Richard Selden
ANDE

Other companies like ANDE in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 

News

ANDE Corporation, the global leader in Rapid DNA, announced the immediate availability of the F7-Chip